<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="rapid-communication" dtd-version="2.3">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">molbank</journal-id>
      <journal-title>Molbank</journal-title>
      <abbrev-journal-title abbrev-type="publisher">Molbank</abbrev-journal-title>
      <abbrev-journal-title abbrev-type="pubmed">Molbank</abbrev-journal-title>
      <issn pub-type="epub">1422-8599</issn>
      <publisher>
        <publisher-name>MDPI</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3390/M706</article-id>
      <article-id pub-id-type="publisher-id">molbank-2010-M706</article-id>
      <article-categories>
        <subj-group>
          <subject>Short Note</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>5-Dimethylamino-1-phenylchromeno[2,3-<italic>c</italic>]pyrazol-4(1<italic>H</italic>)-one</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Ebner</surname>
            <given-names>Angelika</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Holzer</surname>
            <given-names>Wolfgang</given-names>
          </name>
          <xref rid="c1-molbank-2010-M706" ref-type="corresp">*</xref>
        </contrib>
      </contrib-group>
      <aff id="af1-molbank-2010-M706">Department of Drug and Natural Product Synthesis, Faculty of Life Sciences, University of Vienna, Althanstrasse 14, A-1090 Vienna, Austria</aff>
      <author-notes>
        <corresp id="c1-molbank-2010-M706"><label>*</label>Author to whom correspondence should be addressed; E-Mail: <email>wolfgang.holzer@univie.ac.at</email>.</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>05</day>
        <month>11</month>
        <year>2010</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>12</month>
        <year>2010</year>
      </pub-date>
      <volume>2010</volume>
      <issue>4</issue>
      <elocation-id>M706</elocation-id>
      <history>
        <date date-type="received">
          <day>09</day>
          <month>10</month>
          <year>2010</year>
        </date>
        <date date-type="accepted">
          <day>04</day>
          <month>11</month>
          <year>2010</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2010 by the authors; licensee MDPI, Basel, Switzerland.</copyright-statement>
        <copyright-year>2010</copyright-year>
        <license>
          <p>This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).</p>
        </license>
      </permissions>
      <abstract>
        <p>The title compound was prepared by treatment of 5-fluoro-1-phenylchromeno[2,3-<italic>c</italic>]pyrazol-4(1<italic>H</italic>)-one with aqueous dimethylamine. Detailed spectroscopic data (<sup>1</sup>H NMR, <sup>13</sup>C NMR, <sup>15</sup>N NMR, IR, MS) are presented.</p>
      </abstract>
      <kwd-group>
        <kwd>chromeno[2,3-<italic>c</italic>]pyrazol-4(1<italic>H</italic>)-one</kwd>
        <kwd>nucleophilic substitution</kwd>
        <kwd>DMF</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
      <p>In the course of a program devoted to the synthesis of new heterocyclic scaffolds we recently presented the synthesis of various heterocyclic xanthone analogues of type <bold>A</bold> containing a [5,6]pyrano[2,3-<italic>c</italic>]pyrazol-4(1<italic>H</italic>)-one substructure (<xref ref-type="fig" rid="molbank-2010-M706-f001">Figure 1</xref>) [<xref ref-type="bibr" rid="B1-molbank-2010-M706">1</xref>,<xref ref-type="bibr" rid="B2-molbank-2010-M706">2</xref>,<xref ref-type="bibr" rid="B3-molbank-2010-M706">3</xref>,<xref ref-type="bibr" rid="B4-molbank-2010-M706">4</xref>,<xref ref-type="bibr" rid="B5-molbank-2010-M706">5</xref>,<xref ref-type="bibr" rid="B6-molbank-2010-M706">6</xref>,<xref ref-type="bibr" rid="B7-molbank-2010-M706">7</xref>]. In these compounds, one benzene ring of the parent xanthone is replaced by a pyrazole system and the other one by a variable heteroaromatic moiety or by a (substituted) benzene ring.</p>
      <p>Due to the importance of fluorinated compounds in medicinal chemistry [<xref ref-type="bibr" rid="B8-molbank-2010-M706">8</xref>,<xref ref-type="bibr" rid="B9-molbank-2010-M706">9</xref>,<xref ref-type="bibr" rid="B10-molbank-2010-M706">10</xref>,<xref ref-type="bibr" rid="B11-molbank-2010-M706">11</xref>,<xref ref-type="bibr" rid="B12-molbank-2010-M706">12</xref>] we also synthesized appropriate congeners <bold>B</bold> carrying fluoro substituents at different positions of a chromeno[2,3-<italic>c</italic>]pyrazol-4(1<italic>H</italic>)-one scaffold, for instance at positions 5, 6, 7 and 8 (<xref ref-type="fig" rid="molbank-2010-M706-f001">Figure 1</xref>) [<xref ref-type="bibr" rid="B13-molbank-2010-M706">13</xref>]. During the synthesis of 5-fluoro-1-phenylchromeno[2,3-<italic>c</italic>]pyrazol-4(1<italic>H</italic>)-one (<bold>3</bold>, <xref ref-type="scheme" rid="molbank-2010-M706-sch001">Scheme 1</xref>) we observed an interesting phenomenon. The preparation of <bold>3</bold> was accomplished by cyclization of intermediate <bold>2</bold>, which was obtained upon reaction of 1-phenyl-2-pyrazolin-5-one (<bold>1</bold>) with 2,6-difluorobenzoyl chloride under the conditions described by Jensen for the C-4 acylation of pyrazolones (calcium hydroxide, dioxane, reflux) [<xref ref-type="bibr" rid="B14-molbank-2010-M706">14</xref>]. When the cyclization of <bold>2</bold> (NaH/DMF) was carried out under forced conditions and prolonged heating, besides the desired fluoro compound <bold>3</bold> also the corresponding dimethylamino congener <bold>4</bold> was obtained in increasing extent (<xref ref-type="scheme" rid="molbank-2010-M706-sch001">Scheme 1</xref>). This finding can be accounted to the known decomposition of DMF (<italic>N</italic>,<italic>N</italic>-dimethylformamide) at its boiling temperature, leading to the liberation of dimethylamine [<xref ref-type="bibr" rid="B15-molbank-2010-M706">15</xref>]. This process can also occur at lower temperatures when catalyzed by basic or acidic materials [<xref ref-type="bibr" rid="B15-molbank-2010-M706">15</xref>]. This special property of DMF has been actually utilized for <italic>N</italic>,<italic>N</italic>-dimethylaminations of reactive aryl or benzyl halides with DMF, either in the presence or absence of catalysts [<xref ref-type="bibr" rid="B16-molbank-2010-M706">16</xref>]. Also the conversion of active haloheteroarenes into the corresponding <italic>N</italic>,<italic>N</italic>-dimethylamino compounds has been described in this way, as an example the synthesis of 6-chloro-3-(dimethylamino)pyridazine from 3,6-dichloropyridazine (95% yield) via 48 hours reflux in DMF solution may serve [<xref ref-type="bibr" rid="B16-molbank-2010-M706">16</xref>].</p>
      <p>For comparison purposes, we prepared amine <bold>4</bold> in an alternative way, <italic>i.e.</italic> by reaction of <bold>3</bold> with excess aqueous dimethylamine. The latter procedure is definitely advantageous compared to the above mentioned one, as here the title compound is smoothly obtained under mild conditions without any by-products, thus superseding a chromatographic separation (<xref ref-type="scheme" rid="molbank-2010-M706-sch001">Scheme 1</xref>).</p>
      <p>A detailed characterization of compound <bold>4</bold> including IR, MS and NMR (<sup>1</sup>H, <sup>13</sup>C, <sup>15</sup>N) spectral data as well as microanalytical data is given in the Experimental. Full and unambiguous assignment of all <sup>1</sup>H, <sup>13</sup>C and <sup>15</sup>N NMR resonances was achieved by combined application of standard NMR spectroscopic techniques such as <sup>1</sup>H-coupled <sup>13</sup>C-NMR (gated decoupling), APT, COSY, NOESY, gs-HSQC and gs-HMBC [<xref ref-type="bibr" rid="B17-molbank-2010-M706">17</xref>].</p>
    <sec sec-type="methods">
      <title>Experimental</title>
      <p>The melting point was determined on a Kofler hot-stage microscope and is uncorrected. The mass spectrum was obtained on a Shimadzu QP 1000 instrument (EI, 70 eV), the IR spectrum on a Perkin-Elmer FTIR 1605 spectrophotometer (KBr-disc). The elemental analysis was performed at the Microanalytical Laboratory, University of Vienna. All NMR spectra were recorded from CDCl<sub>3</sub> solutions on a Bruker Avance 500 instrument with a &#x2018;directly&#x2019; detecting broadband observe probe (BBFO) at 298 K (500.13 MHz for <sup>1</sup>H, 125.76 MHz for <sup>13</sup>C, 50.68 MHz for <sup>15</sup>N). The centre of the solvent signal was used as an internal standard which was related to TMS with &#x3B4; = 7.26 ppm (<sup>1</sup>H in CDCl<sub>3</sub>) and &#x3B4; = 77.0 ppm (<sup>13</sup>C in CDCl<sub>3</sub>). The digital resolutions were 0.2 Hz/data point in the <sup>1</sup>H and 0.4 Hz/data point in the <sup>1</sup>H-coupled <sup>13</sup>C-NMR spectra (gated decoupling). The <sup>15</sup>N NMR spectrum (gradient-selected <sup>15</sup>N,<sup>1</sup>H-HMBC) was referenced against external nitromethane.</p>
      <sec>
        <title>5-Dimethylamino-1-phenylchromeno[2,3-<italic>c</italic>]pyrazol-4(1<italic>H</italic>)-one (<bold>4</bold>)</title>
        <p>In a reaction flask closed with a balloon, to a solution of 5-fluoro-1-phenylchromeno[2,3-<italic>c</italic>]pyrazol-4(1<italic>H</italic>)-one (<bold>3</bold>) (28 mg, 0.1 mmol) in 1,4-dioxane (4 mL) was portionwise added an aqueous solution (40%) of dimethylamine (400 &#x3BC;L) via syringe. Then the mixture was stirred at room temperature for 3 hours. Evaporation of the solvents under reduced pressure produced a light-colored residue which was washed with water and dried to afford 23 mg (75%) of chromatographically pure <bold>4</bold>. For analytical purposes the material was recrystallized from EtOH to give 19 mg (62%) of <bold>4</bold> as yellowish crystals with mp 184&#x2013;186 &#xB0;C.</p>
        <p>IR (KBr) &#x3BD; (cm<sup>&#x2212;1</sup>): 1651 (C=O).</p>
        <p>MS (EI, 70 eV): (<italic>m/z</italic>, %) 305 (M<sup>+</sup>, 32), 291 (20), 290 (100), 276 (52), 121 (15), 77 (31) 51 (28).</p>
        <p><sup>1</sup>H NMR (CDCl<sub>3</sub>): &#x3B4; (ppm) 2.98 (s, 6H, NMe<sub>2</sub>), 6.90 (dd, 1H, H-6, <sup>3</sup><italic>J</italic>(H6,H7) = 8.3 Hz, <sup>4</sup><italic>J</italic>(H6,H8) = 1.0 Hz), 6.96 (dd, 1H, H-8, <sup>3</sup><italic>J</italic>(H8,H7) = 8.2 Hz, <sup>4</sup><italic>J</italic>(H8,H6) = 1.0 Hz), 7.40 (m, 1H, Ph H-4), 7.47 (dd, 1H, H-7, <sup>3</sup><italic>J</italic>(H7,H6) = 8.3 Hz, <sup>3</sup><italic>J</italic>(H7,H8) = 8.2 Hz), 7.55 (m, 2H, Ph H-3,5), 7.90 (m, 2H, Ph H-2,6), 8.18 (s, 1H, H-3).</p>
        <p><sup>13</sup>C NMR (CDCl<sub>3</sub>): &#x3B4; (ppm) 44.8 (NMe<sub>2</sub>, <sup>1</sup><italic>J</italic> = 136.3 Hz, <sup>3</sup><italic>J</italic> = 4.1 Hz), 107.7 (C-3a, <sup>3</sup><italic>J</italic>(C3a,H3) = 9.8 Hz), 108.1 (C-8), 112.9 (C-6), 113.4 (C-4a), 121.0 (Ph C-2,6), 127.4 (Ph C-4), 129.4 (Ph C-3,5), 133.0 (C-7, <sup>1</sup><italic>J</italic> = 160.9 Hz), 136.8 (C-3, <sup>1</sup><italic>J</italic> = 193.6 Hz), 137.3 (Ph C-1), 151.6 (C-9a, <sup>3</sup><italic>J</italic>(C9a,H3) = 4.8 Hz), 154.4 (C-5), 157.9 (C-8a), 172.6 (C-4).</p>
        <p><sup>15</sup>N NMR (CDCl<sub>3</sub>): &#x3B4; (ppm) &#x2013;325.5 (NMe), &#x2013;188.8 (N-1), &#x2013;91.7 (N-2).</p>
        <p>Anal. Calcd for C<sub>18</sub>H<sub>15</sub>N<sub>3</sub>O<sub>2</sub>: C, 70.81%; H, 4.95%; N, 13.76%. Found: C, 70.47%; H, 4.73%; N 13.54%.</p>
      </sec>
    </sec>
  </body>
  <back>
  <app-group>
    <app id="app1-molbank-2010-M706">
        <title>Supplementary materials</title>
        <supplementary-material id="molbank-2010-M706-s001" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2010-M706-s001-mod.mol">
   <label>Supplementary File 1</label>
    </supplementary-material>
        <supplementary-material id="molbank-2010-M706-s002" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2010-M706-s001.mol">
   <label>Supplementary File 2</label>
</supplementary-material>
    </app>
</app-group>
    <ref-list>
      <title>References and Notes</title>
      <ref id="B1-molbank-2010-M706">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eller</surname>
              <given-names>G.A.</given-names>
            </name>
            <name>
              <surname>Wimmer</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Haring</surname>
              <given-names>A.W.</given-names>
            </name>
            <name>
              <surname>Holzer</surname>
              <given-names>W.</given-names>
            </name>
          </person-group>
          <article-title>An Efficient Approach to Heterocyclic Analogues of Xanthone: A Short Synthesis of All Possible Pyrido[5,6]pyrano[2,3-<italic>c</italic>]pyrazol-4(1<italic>H</italic>)-ones</article-title>
          <source>Synthesis</source>
          <year>2006</year>
          <fpage>4219</fpage>
          <lpage>4229</lpage>
          <pub-id pub-id-type="doi">10.1055/s-2006-950324</pub-id>
        </citation>
      </ref>
      <ref id="B2-molbank-2010-M706">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eller</surname>
              <given-names>G.A.</given-names>
            </name>
            <name>
              <surname>Haring</surname>
              <given-names>A.W.</given-names>
            </name>
            <name>
              <surname>Datterl</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Zwettler</surname>
              <given-names>M.</given-names>
            </name>
			<name>
              <surname>Holzer</surname>
              <given-names>W.</given-names>
            </name>
          </person-group>
          <article-title>Tri- and Tetracyclic Heteroaromatic Systems: Synthesis of Novel Benzo-, Benzothieno- and Thieno-Fused Pyrano[2,3-<italic>c</italic>]pyrazol-4(1<italic>H</italic>)-ones</article-title>
          <source>Heterocycles</source>
          <year>2007</year>
          <volume>71</volume>
          <fpage>87</fpage>
          <lpage>104</lpage>
        </citation>
      </ref>
      <ref id="B3-molbank-2010-M706">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eller</surname>
              <given-names>G.A.</given-names>
            </name>
            <name>
              <surname>Holzer</surname>
              <given-names>W.</given-names>
            </name>
          </person-group>
          <article-title>A Convenient Approach to Heterocyclic Building Blocks: Synthesis of Novel Ring Systems Containing a [5,6]Pyrano[2,3-<italic>c</italic>]pyrazol-4(1<italic>H</italic>)-one Moiety</article-title>
          <source>Molecules</source>
          <year>2007</year>
          <volume>12</volume>
          <fpage>60</fpage>
          <lpage>73</lpage>
          <pub-id pub-id-type="doi">10.3390/12010060</pub-id>
          <pub-id pub-id-type="pmid">17693953</pub-id>
        </citation>
      </ref>
      <ref id="B4-molbank-2010-M706">
        <label>4.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eller</surname>
              <given-names>G.A.</given-names>
            </name>
            <name>
              <surname>Datterl</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Holzer</surname>
              <given-names>W.</given-names>
            </name>
          </person-group>
          <article-title>Pyrazolo[4&#x2019;,3&#x2019;:5,6]pyrano[2,3-<italic>b</italic>]quinoxalin-4(1<italic>H</italic>)-one: Synthesis and Characterization of a Novel Tetracyclic Ring System</article-title>
          <source>J. Heterocycl. Chem.</source>
          <year>2007</year>
          <volume>44</volume>
          <fpage>1139</fpage>
          <lpage>1143</lpage>
          <pub-id pub-id-type="doi">10.1002/jhet.5570440526</pub-id>
        </citation>
      </ref>
      <ref id="B5-molbank-2010-M706">
        <label>5.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eller</surname>
              <given-names>G.A.</given-names>
            </name>
            <name>
              <surname>Wimmer</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Holzer</surname>
              <given-names>W.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis of Novel Polycyclic Ring Systems Containing Two Pyrano[2,3-<italic>c</italic>]pyrazol-4(1<italic>H</italic>)-one Moieties</article-title>
          <source>Khim. Geterotsikl. Soedin.</source>
          <year>2007</year>
          <fpage>1251</fpage>
          <lpage>1255</lpage>
		  <comment><italic>Chem. Heterocycl. Comp.</italic> <bold>2007</bold>, <italic>43</italic>, 1060&#x2013;1064</comment>
        </citation>
      </ref>
      <ref id="B6-molbank-2010-M706">
        <label>6.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eller</surname>
              <given-names>G.A.</given-names>
            </name>
            <name>
              <surname>Habicht</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Holzer</surname>
              <given-names>W.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis of a Novel Pentacycle: 8-Methyl-10-phenylpyrazolo[4&#x2019;,3&#x2019;:5,6]pyrano[3,2-<italic>c</italic>][1,10]phenanthrolin-7(10<italic>H</italic>)-one</article-title>
          <source>Khim. Geterotsikl. Soedin.</source>
          <year>2008</year>
          <fpage>884</fpage>
          <lpage>890</lpage>
		  <comment><italic>Chem. Heterocycl. Comp.</italic> <bold>2008</bold>, <italic>44</italic>, 709&#x2013;714</comment>
        </citation>
      </ref>
      <ref id="B7-molbank-2010-M706">
        <label>7.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eller</surname>
              <given-names>G.A.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Q.</given-names>
            </name>
            <name>
              <surname>Habicht</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Datterl</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Holzer</surname>
              <given-names>W.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and NMR Data of Pyrazolo[4&#x2019;,3&#x2019;:5,6]pyrano[2,3-<italic>b</italic>]pyrazin-4(1<italic>H</italic>)-ones: Derivatives of a Novel Tricyclic Ring System</article-title>
          <source>Acta Chim. Slov.</source>
          <year>2009</year>
          <volume>56</volume>
          <fpage>521</fpage>
          <lpage>526</lpage>
        </citation>
      </ref>
      <ref id="B8-molbank-2010-M706">
        <label>8.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>B&#xF6;hme</surname>
              <given-names>H.-J.</given-names>
            </name>
            <name>
              <surname>Banner</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Bendels</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Kansy</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kuhn</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>M&#xFC;ller</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Obst-Sander</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Stahl</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Fluorine in Medicinal Chemistry</article-title>
          <source>ChemBioChem</source>
          <year>2004</year>
          <volume>5</volume>
          <fpage>637</fpage>
          <lpage>643</lpage>
          <pub-id pub-id-type="doi">10.1002/cbic.200301023</pub-id>
          <pub-id pub-id-type="pmid">15122635</pub-id>
        </citation>
      </ref>
      <ref id="B9-molbank-2010-M706">
        <label>9.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hagmann</surname>
              <given-names>W.K.</given-names>
            </name>
          </person-group>
          <article-title>The Many Roles for Fluorine in Medicinal Chemistry</article-title>
          <source>J. Med. Chem.</source>
          <year>2008</year>
          <volume>51</volume>
          <fpage>4359</fpage>
          <lpage>4369</lpage>
          <pub-id pub-id-type="doi">10.1021/jm800219f</pub-id>
          <pub-id pub-id-type="pmid">18570365</pub-id>
        </citation>
      </ref>
      <ref id="B10-molbank-2010-M706">
        <label>10.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Sharon</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Chu</surname>
              <given-names>C.K.</given-names>
            </name>
          </person-group>
          <article-title>Fluorinated nucleosides: Synthesis and biological implication</article-title>
          <source>J. Fluorine Chem.</source>
          <year>2008</year>
          <volume>129</volume>
          <fpage>129743</fpage>
          <lpage>129766</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jfluchem.2008.06.007</pub-id>
          <pub-id pub-id-type="pmid">19727318</pub-id>
        </citation>
      </ref>
      <ref id="B11-molbank-2010-M706">
        <label>11.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Berkowitz</surname>
              <given-names>D.B.</given-names>
            </name>
            <name>
              <surname>Karukurichi</surname>
              <given-names>K.R.</given-names>
            </name>
            <name>
              <surname>de la Salud-Bea</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Nelson</surname>
              <given-names>D.L.</given-names>
            </name>
            <name>
              <surname>McCune</surname>
              <given-names>C.D.</given-names>
            </name>
          </person-group>
          <article-title>Use of fluorinated functionality in enzyme inhibitor development: Mechanistic and analytical advantages</article-title>
          <source>J. Fluorine Chem.</source>
          <year>2008</year>
          <volume>129</volume>
          <fpage>731</fpage>
          <lpage>742</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jfluchem.2008.05.016</pub-id>
          <pub-id pub-id-type="pmid">19727327</pub-id>
        </citation>
      </ref>
      <ref id="B12-molbank-2010-M706">
        <label>12.</label>
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Ojima</surname>
              <given-names>I.</given-names>
            </name>
          </person-group>
		  <source>Fluorine in Medicinal Chemistry And Chemical Biology</source>
		  <publisher-name>Wiley</publisher-name>
		  <publisher-loc>Chichester, UK</publisher-loc>
          <year>2009</year>
		  <comment><italic>Chem. Abstr.</italic> <bold>2009</bold>, <italic>152</italic>, 399832</comment>
        </citation>
      </ref>
      <ref id="B13-molbank-2010-M706">
        <label>13.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Holzer</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Ebner</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Schalle</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Batezila</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Eller</surname>
              <given-names>G.A.</given-names>
            </name>
          </person-group>
          <article-title>Novel fluoro-substituted benzo- and benzothieno fused pyrano[2,3-<italic>c</italic>]pyrazol-4(1<italic>H</italic>)-ones</article-title>
          <source>J. Fluorine Chem.</source>
          <year>2010</year>
          <volume>131</volume>
          <fpage>1013</fpage>
          <lpage>1024</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jfluchem.2010.07.007</pub-id>
        </citation>
      </ref>
      <ref id="B14-molbank-2010-M706">
        <label>14.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jensen</surname>
              <given-names>B.S.</given-names>
            </name>
          </person-group>
          <article-title>The Synthesis of 1-Phenyl-3-methyl-4-acyl-pyrazolones-5</article-title>
          <source>Acta Chem. Scand.</source>
          <year>1959</year>
          <volume>13</volume>
          <fpage>1668</fpage>
          <lpage>1670</lpage>
		  <comment><italic>Chem. Abstr.</italic> <bold>1962</bold>, <italic>56</italic>, 66890</comment>
        </citation>
      </ref>
      <ref id="B15-molbank-2010-M706">
        <label>15.</label>
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Perrin</surname>
              <given-names>D.D.</given-names>
            </name>
            <name>
              <surname>Armarego</surname>
              <given-names>W.L.F.</given-names>
            </name>
            <name>
              <surname>Perrin</surname>
              <given-names>D.R.</given-names>
            </name>
          </person-group>
          <source>Purification of Laboratory Chemicals</source>
          <edition>2nd ed.</edition>
          <publisher-name>Pergamon Press</publisher-name>
          <publisher-loc>Oxford, UK</publisher-loc>
          <year>1980</year>
          <fpage>224</fpage>
        </citation>
      </ref>
      <ref id="B16-molbank-2010-M706">
        <label>16.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>W.S.</given-names>
            </name>
            <name>
              <surname>Yoon</surname>
              <given-names>Y.-J.</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>S.-K.</given-names>
            </name>
          </person-group>
          <article-title>Reaction of Chloropyridazines with <italic>N</italic>,<italic>N</italic>- Dimethylformamide</article-title>
          <source>J. Heterocycl. Chem.</source>
          <year>2000</year>
          <volume>37</volume>
          <fpage>1591</fpage>
          <lpage>1595</lpage>
          <pub-id pub-id-type="doi">10.1002/jhet.5570370630</pub-id>
        </citation>
      </ref>
      <ref id="B17-molbank-2010-M706">
        <label>17.</label>
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Braun</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Kalinowski</surname>
              <given-names>H.-O.</given-names>
            </name>
            <name>
              <surname>Berger</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
		  <source>150 and More Basic NMR Experiments: A Practical Course &#x2013; Second Expanded Edition</source>
		  <publisher-name>Wiley&#x2013;VCH</publisher-name>
		  <publisher-loc>Weinheim, Germany</publisher-loc>
          <year>1998</year>
		  <comment><italic>Chem. Abstr.</italic> <bold>1999</bold>, <italic>131</italic>, 184497</comment>
        </citation>
      </ref>
    </ref-list>
    <sec sec-type="display-objects">
      <title>Figure and Scheme</title>
      <fig id="molbank-2010-M706-f001" position="float">
        <label>Figure 1</label>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2010-M706-g001.tif"/>
      </fig>
      <fig id="molbank-2010-M706-sch001" position="float">
        <object-id pub-id-type="pii">molbank-2010-M706-sch001_Scheme 1</object-id>
        <label>Scheme 1</label>
        <caption>
          <p>Synthesis of compounds <bold>3</bold> and <bold>4</bold>.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2010-M706-sch001.tif"/>
      </fig>
    </sec>
  </back>
</article>
